FutureTech II Acquisition Corp. (FTII)

NASDAQ: FTII · Real-Time Price · USD
11.25
+0.16 (1.44%)
Dec 17, 2024, 4:00 PM EST - Market closed
3.69%
Market Cap 65.58M
Revenue (ttm) n/a
Net Income (ttm) 1.35M
Shares Out 5.83M
EPS (ttm) 0.16
PE Ratio 71.55
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4
Open 11.25
Previous Close 11.09
Day's Range 11.25 - 11.25
52-Week Range 10.83 - 12.48
Beta 0.00
Analysts n/a
Price Target n/a
Earnings Date n/a

About FTII

FutureTech II Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on business operating in the technology industry, including artificial intelligence (AI), robotic process automation, and other related technology market. FutureTech II Acquisition Corp. was founded in 2021 and is based in New Rochelle, New York. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Feb 16, 2022
Employees 2
Stock Exchange NASDAQ
Ticker Symbol FTII
Full Company Profile

Financial Performance

Financial Statements

News

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it received an expected deficiency notification letter from t...

17 days ago - GlobeNewsWire

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

New York, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Longevity Biomedical, Inc. (“Longevity” or “Longevity Biomedical”), a biopharmaceutical company focused on advancing new technologies across therapeutics, ...

3 months ago - GlobeNewsWire

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (Nasdaq: FTIIU) (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock ex...

1 year ago - GlobeNewsWire

FutureTech II Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants

NEW ROCHELLE, NY / ACCESSWIRE / April 8, 2022 / FutureTech II Acquisition Corp. (Nasdaq:FTIIU) (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchan...

2 years ago - Accesswire